These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 840632)
21. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Invernizzi P; Crosignani A; Battezzati PM; Covini G; De Valle G; Larghi A; Zuin M; Podda M Hepatology; 1997 May; 25(5):1090-5. PubMed ID: 9141422 [TBL] [Abstract][Full Text] [Related]
22. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467 [TBL] [Abstract][Full Text] [Related]
23. Elevated level of serum Mn-superoxide dismutase in patients with primary biliary cirrhosis: possible involvement of free radicals in the pathogenesis in primary biliary cirrhosis. Ono M; Sekiya C; Ohhira M; Ohhira M; Namiki M; Endo Y; Suzuki K; Matsuda Y; Taniguchi N J Lab Clin Med; 1991 Nov; 118(5):476-83. PubMed ID: 1682406 [TBL] [Abstract][Full Text] [Related]
24. Serum immunological profile in patients with chronic autoimmune cholestasis. Romero-Gómez M; Wichmann I; Crespo J; Parés A; Rodrigo L; Alvarez A; Diago M; Pons-Romero F; Sanchez-Munoz D; Aguilar-Reina J; Andrade RJ; Salmeron J; Sánchez-Pobre P; Rebollo JM; Martin-Vivaldi R; Castellano-Megias V; Nuñez-Roldan A; Bruguera M; Am J Gastroenterol; 2004 Nov; 99(11):2150-7. PubMed ID: 15554996 [TBL] [Abstract][Full Text] [Related]
25. [Immunoserologic differentiation of chronic cholestatic hepatitis. Significance of antimitochondrial antibodies and hepatic membrane antibodies]. Hopf U; Möller B; Lobeck H; Klein R; Berg PA Dtsch Med Wochenschr; 1985 Dec; 110(50):1924-9. PubMed ID: 3908047 [TBL] [Abstract][Full Text] [Related]
26. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Rigopoulou EI; Davies ET; Bogdanos DP; Liaskos C; Mytilinaiou M; Koukoulis GK; Dalekos GN; Vergani D Liver Int; 2007 Nov; 27(9):1226-31. PubMed ID: 17919234 [TBL] [Abstract][Full Text] [Related]
27. Can the laboratory affect the investigation and diagnosis of primary biliary cirrhosis? Sinclair D; Spedding A; Young R J Clin Pathol; 2006 Apr; 59(4):360-2. PubMed ID: 16461570 [TBL] [Abstract][Full Text] [Related]
28. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis. Tanaka A; Nezu S; Uegaki S; Mikami M; Okuyama S; Kawamura N; Aiso M; Gershwin ME; Takahashi S; Selmi C; Takikawa H Ann N Y Acad Sci; 2007 Jun; 1107():259-70. PubMed ID: 17804554 [TBL] [Abstract][Full Text] [Related]
29. No prognostic significance of antimitochondrial antibody profile testing in primary biliary cirrhosis. Vleggaar FP; van Buuren HR Hepatogastroenterology; 2004; 51(58):937-40. PubMed ID: 15239218 [TBL] [Abstract][Full Text] [Related]
30. Characterization of primary biliary cirrhosis (PBC) specific mitochondrial determinants by immunoblotting. Manns M; Gerken G; Trautwein C; Meuer M; Porally T; Dienes HP; Meyer zum Büschenfelde KH Dtsch Z Verdau Stoffwechselkr; 1987; 47(2):59-66. PubMed ID: 2441951 [TBL] [Abstract][Full Text] [Related]
31. [Positive rate of anti-mitochondrial antibody in Japanese corporate workers]. Koizumi H; Onozuka Y; Shibata M; Sano K; Ooshima Y; Morizane T; Ueno Y Rinsho Byori; 2000 Oct; 48(10):966-70. PubMed ID: 11215112 [TBL] [Abstract][Full Text] [Related]
33. [What is the onset of primary biliary liver cirrhosis?]. Linhart P; Börner N; Leiss O Z Gastroenterol; 1993 Feb; 31 Suppl 2():94-5. PubMed ID: 7483729 [TBL] [Abstract][Full Text] [Related]
34. [Histological and clinical studies on the differential diagnosis of the aggressive chronic hepatitis and primary biliary liver cirrhosis]. Lüders CJ; Kruck P; Henning H; Look D Z Gastroenterol; 1974 Oct; 12(6):467-84. PubMed ID: 4428821 [No Abstract] [Full Text] [Related]
35. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Miyakawa H; Tanaka A; Kikuchi K; Matsushita M; Kitazawa E; Kawaguchi N; Fujikawa H; Gershwin ME Hepatology; 2001 Aug; 34(2):243-8. PubMed ID: 11481607 [TBL] [Abstract][Full Text] [Related]
36. [Prevalence of antinuclear antibodies in primary biliary cirrhosis, with negative antimitochondrial antibodies]. Antonio Olivera M; Zapata L; Kaplan M; Bobadilla J; Corte G; de la Mora G; Uribe M; Cabiedes J; Dehesa M; Kershenobich D Rev Gastroenterol Mex; 1993; 58(3):220-2. PubMed ID: 8165399 [TBL] [Abstract][Full Text] [Related]
37. Response to treatment with interferon-alfa in patients with chronic hepatitis C and high titers of -M2, -M4 and -M8 antimitochondrial antibodies. Garrido Palma G; Sánchez Cuenca JM; Olaso V; Pina R; Urquijo JJ; López Viedma B; Bustamante M; Berenguer M; Berenguer J Rev Esp Enferm Dig; 1999 Mar; 91(3):168-81. PubMed ID: 10231308 [TBL] [Abstract][Full Text] [Related]
38. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512 [TBL] [Abstract][Full Text] [Related]
39. Primary biliary cirrhosis in Lithuania: diagnosis and clinical picture. Speiciene D; Irnius A; Leuschner U; Liakina V; Semuchiniene T; Barakauskiene A Med Sci Monit; 2007 Jul; 13(7):CR299-306. PubMed ID: 17599023 [TBL] [Abstract][Full Text] [Related]
40. Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the 'phase' of the disease? Kadokawa Y; Omagari K; Ohba K; Masuda J; Hazama H; Kinoshita H; Ohnita K; Mizuta Y; Tanioka H; Imanishi T; Kohno S Liver Int; 2005 Apr; 25(2):317-24. PubMed ID: 15780056 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]